![Determination of an individual’s risk for severe arrhythmias before a life-threatening event occurs remains a significant medical challenge. [© kmiragaya - Fotolia.com]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/75.jpeg "Determination of an individual’s risk for severe arrhythmias before a life-threatening event occurs remains a significant medical challenge. [© kmiragaya - Fotolia.com]")
Advances in molecular diagnostics, physicians say, have the potential to improve identification of cardiac diseases and further understanding of mechanisms responsible for their pathogenesis and phenotypic expression. These tests may also predict the need for specific treatment, or help avoid unnecessary therapies and invasive diagnostic procedures.
And, scientists add, while genomic research in cardiovascular disease (CVD) has progressed rapidly over the last few years, “groundbreaking observations” have not yet been accompanied by clinically applicable tools for risk prediction, diagnosis, or therapeutic interventions.
For the rest of the story, click here.
